Long-term Survival Following Partial vs Radical Nephrectomy Among Older Patients With Early-Stage Kidney Cancer | Nephrology | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
1.
Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States.  JAMA. 1999;281(17):1628-163110235157PubMedGoogle ScholarCrossref
2.
Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect.  J Natl Cancer Inst. 2006;98(18):1331-133416985252PubMedGoogle ScholarCrossref
3.
Howlader N, Noone AM, Krapcho M,  et al.  SEER Cancer Statistics Review, 1975-2008: Bethesda, MD, National Cancer Institute, November 10, 2011. http://seer.cancer.gov/csr/1975_2008/. Accessed January 30, 2012
4.
Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.  J Urol. 2000;163(2):442-44510647650PubMedGoogle ScholarCrossref
5.
Huang WC, Levey AS, Serio AM,  et al.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.  Lancet Oncol. 2006;7(9):735-74016945768PubMedGoogle ScholarCrossref
6.
Novick AC, Campbell SC, Belldegrun A,  et al.  Guideline for management of the clinical stage 1 renal mass. http://www.auanet.org/content/media/renalmass09.pdf. Accessed January 30, 2012
7.
Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.  Mayo Clin Proc. 2000;75(12):1236-124211126830PubMedGoogle ScholarCrossref
8.
Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors–is there a difference in mortality and cardiovascular outcomes?  J Urol. 2009;181(1):55-6119012918PubMedGoogle ScholarCrossref
9.
Zini L, Perrotte P, Capitanio U,  et al.  Radical versus partial nephrectomy: effect on overall and noncancer mortality.  Cancer. 2009;115(7):1465-147119195042PubMedGoogle ScholarCrossref
10.
Thompson RH, Boorjian SA, Lohse CM,  et al.  Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.  J Urol. 2008;179(2):468-47118076931PubMedGoogle ScholarCrossref
11.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.  N Engl J Med. 2004;351(13):1296-130515385656PubMedGoogle ScholarCrossref
12.
Van Poppel H, Da Pozzo L, Albrecht W,  et al.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.  Eur Urol. 2010;59(4):543-55221186077PubMedGoogle ScholarCrossref
13.
Miller DC, Hollingsworth JM, Hafez KS, Daignault S, Hollenbeck BK. Partial nephrectomy for small renal masses: an emerging quality of care concern?  J Urol. 2006;175(3 pt 1):853-85716469564PubMedGoogle ScholarCrossref
14.
Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables.  Annu Rev Public Health. 1998;19:17-349611610PubMedGoogle ScholarCrossref
15.
Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods.  JAMA. 2007;297(3):278-28517227979PubMedGoogle ScholarCrossref
16.
Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource.  Cancer Epidemiol Biomarkers Prev. 1999;8(12):1117-112110613347PubMedGoogle Scholar
17.
Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.  Med Care. 2002;40(8):(suppl)  IV-3-IV-1812187163PubMedGoogle Scholar
18.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010
19.
Miller DC, Saigal CS, Warren JL,  et al.  External validation of a claims-based algorithm for classifying kidney-cancer surgeries.  BMC Health Serv Res. 2009;9:92-9819500395PubMedGoogle ScholarCrossref
20.
Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations.  Med Care. 2002;40(8):(suppl)  IV-19-IV-2512187164PubMedGoogle Scholar
21.
Morrill R, Cromartie J, Hart G. Metropolitan, urban, and rural communting areas: toward a better depiction of the United States settlement system.  Urban Geogr. 1999;20:727-748Google ScholarCrossref
22.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.  J Clin Epidemiol. 1992;45(6):613-6191607900PubMedGoogle ScholarCrossref
23.
Weingart SN, Iezzoni LI, Davis RB,  et al.  Use of administrative data to find substandard care: validation of the complications screening program.  Med Care. 2000;38(8):796-80610929992PubMedGoogle ScholarCrossref
24.
Iezzoni LI, Daley J, Heeren T,  et al.  Identifying complications of care using administrative data.  Med Care. 1994;32(7):700-7158028405PubMedGoogle ScholarCrossref
25.
Agency for Healthcare Research and Quality.  Guide to patient safety indicators 2007. http://www.qualityindicators.ahrq.gov/Downloads/Software/SAS/V30/psi_guide_v30.pdf Accessed January 30, 2012
26.
Tan HJ, Wolf JS Jr, Ye Z, Wei JT, Miller DC. Complications and failure to rescue after laparoscopic versus open radical nephrectomy.  J Urol. 2011;186(4):1254-126021849185PubMedGoogle ScholarCrossref
27.
Staiger D, Stock JH. Instumental variables regression with weak instruments.  Econometrica. 1997;65(3):557-586Google ScholarCrossref
28.
Terza JV, Basu A, Rathouz PJ. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.  J Health Econ. 2008;27(3):531-54318192044PubMedGoogle ScholarCrossref
29.
Terza JV, Bradford WD, Dismuke CE. The use of linear instrumental variables methods in health services research and health economics: a cautionary note.  Health Serv Res. 2008;43(3):1102-112018546544PubMedGoogle ScholarCrossref
30.
Gill IS, Kavoussi LR, Lane BR,  et al.  Comparison of 1800 laparoscopic and open partial nephrectomies for single renal tumors.  J Urol. 2007;178(1):41-4617574056PubMedGoogle ScholarCrossref
31.
Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?  Urology. 2006;67(2):254-25916442601PubMedGoogle ScholarCrossref
32.
Russo P, Jang TL, Pettus JA,  et al.  Survival rates after resection for localized kidney cancer: 1989 to 2004.  Cancer. 2008;113(1):84-9618470927PubMedGoogle ScholarCrossref
33.
Miller DC, Schonlau M, Litwin MS, Lai J, Saigal CS.Urologic Diseases in America Project.  Renal and cardiovascular morbidity after partial or radical nephrectomy.  Cancer. 2008;112(3):511-52018072263PubMedGoogle ScholarCrossref
34.
Novick AC. The role of renal-sparing surgery for renal cell carcinoma.  Semin Urol. 1992;10(1):12-151565898PubMedGoogle Scholar
35.
Dulabon LM, Lowrance WT, Russo P, Huang WC. Trends in renal tumor surgery delivery within the United States.  Cancer. 2010;116(10):2316-232120225227PubMedGoogle Scholar
36.
Cooperberg MR, Mallin K, Kane CJ, Carroll PR. Treatment trends for stage I renal cell carcinoma.  J Urol. 2011;186(2):394-39921679982PubMedGoogle ScholarCrossref
37.
Lane BR, Russo P, Uzzo RG,  et al.  Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function.  J Urol. 2011;185(2):421-42721167524PubMedGoogle ScholarCrossref
38.
Thompson RH, Lane BR, Lohse CM,  et al.  Every minute counts when the renal hilum is clamped during partial nephrectomy.  Eur Urol. 2010;58(3):340-34520825756PubMedGoogle ScholarCrossref
39.
Saigal CS, Deibert CM, Lai J, Schonlau M. Disparities in the treatment of patients with IL-2 for metastatic renal cell carcinoma.  Urol Oncol. 2010;28(3):308-31319070518PubMedGoogle ScholarCrossref
40.
Harris KM, Remler DK. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects.  Health Serv Res. 1998;33(5 pt 1):1337-13609865223PubMedGoogle Scholar
41.
Miller DC, Ruterbusch J, Colt JS,  et al.  Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study.  J Urol. 2010;184(6):2254-225820952033PubMedGoogle ScholarCrossref
42.
Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis.  Cancer. 2007;109(9):1763-176817351954PubMedGoogle ScholarCrossref
43.
Van Poppel H, Da Pozzo L, Albrecht W,  et al; European Organization for Research and Treatment of Cancer (EORTC); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); Southwest Oncology Group (SWOG); Eastern Cooperative Oncology Group (ECOG).  A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.  Eur Urol. 2007;51(6):1606-161517140723PubMedGoogle ScholarCrossref
Original Contribution
April 18, 2012

Long-term Survival Following Partial vs Radical Nephrectomy Among Older Patients With Early-Stage Kidney Cancer

Author Affiliations

Author Affiliations: Dow Division of Health Services Research, Department of Urology (Drs Tan and Miller and Mr Ye), Departments of Health Management and Policy (Dr Norton) and Economics (Dr Norton), Center for Healthcare Outcomes & Policy (Drs Norton and Miller), Division of Urologic Oncology, Department of Urology (Drs Hafez and Miller), University of Michigan, Ann Arbor; National Bureau of Economic Research, Cambridge, Massachusetts (Dr Norton); and Department of Urology, University of Washington, Seattle (Dr Gore).

JAMA. 2012;307(15):1629-1635. doi:10.1001/jama.2012.475
Abstract

Context Although partial nephrectomy is the preferred treatment for many patients with early-stage kidney cancer, recent clinical trial data, which demonstrate better survival for patients treated with radical nephrectomy, have generated new uncertainty regarding the comparative effectiveness of these treatment options.

Objective To compare long-term survival after partial vs radical nephrectomy among a population-based patient cohort whose treatment reflects contemporary surgical practice.

Design, Setting, and Patients We performed a retrospective cohort study of Medicare beneficiaries with clinical stage T1a kidney cancer treated with partial or radical nephrectomy from 1992 through 2007. Using an instrumental variable approach to account for measured and unmeasured differences between treatment groups, we fit a 2-stage residual inclusion model to estimate the treatment effect of partial nephrectomy on long-term survival.

Main Outcome Measures Overall and kidney cancer–specific survival.

Results Among 7138 Medicare beneficiaries with early-stage kidney cancer, we identified 1925 patients (27.0%) treated with partial nephrectomy and 5213 patients (73.0%) treated with radical nephrectomy. During a median follow-up of 62 months, 487 (25.3%) and 2164 (41.5%) patients died following partial or radical nephrectomy, respectively. Kidney cancer was the cause of death for 37 patients (1.9%) treated with partial nephrectomy, and 222 patients (4.3%) treated with radical nephrectomy. Patients treated with partial nephrectomy had a significantly lower risk of death (hazard ratio [HR], 0.54; 95% CI, 0.34-0.85). This corresponded with a predicted survival increase with partial nephrectomy of 5.6 (95% CI, 1.9-9.3), 11.8 (95% CI, 3.9-19.7), and 15.5 (95% CI, 5.0-26.0) percentage points at 2, 5, and 8 years posttreatment (P < .001). No difference was noted in kidney cancer–specific survival (HR, 0.82; 95% CI, 0.19-3.49).

Conclusion Among Medicare beneficiaries with early-stage kidney cancer who were candidates for either surgery, treatment with partial rather than radical nephrectomy was associated with improved survival.

×